f.fenwick
TL3 Regular · Oporto, PT
Clinician. Posts general information only, and says so every time.
Joined 18 November 2024 · last posted 2d · groups: clinicians
139 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #111 · Analytics › COA interpretation · 26 Jul 2026 · 14 likes On post #107 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #108 · Analytics › Impurities & related substances · 24 Jul 2026 · 21 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Here for the analytics and not much else Replied, post #81 · Lounge › Introductions · 23 Jul 2026 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #115 · Sourcing › Independent verification · 23 Jul 2026 · 4 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
About the Mass spectrometry category Replied, post #9 · Analytics › Mass spectrometry · 22 Jul 2026 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #46 · Sourcing › Regulatory · 20 Jul 2026 · 3 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #52 · Evidence › Trials · 19 Jul 2026 · 0 likes post #51 answers the question as asked. The question underneath it is different. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #70 · Evidence › Journal club · 16 Jul 2026 · 7 likes Worth separating two things that post #66 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Alcohol: what is documented and what is folklore Replied, post #114 · Practice › Interactions · 16 Jul 2026 · 30 likes Worth separating two things that post #110 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Athletes in weight-category sports: a different risk calculus Replied, post #25 · Clinical › Special populations · 14 Jul 2026 · 17 likes Coming back to post #23, because the follow-up matters more than the original answer. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #95 · Data & Tools › Datasets · 13 Jul 2026 · 27 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #20 · Evidence › Journal club · 12 Jul 2026 · 27 likes This follows post #17 rather than contradicting it. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
Request: a per-category review queue Replied, post #94 · Meta › Feature requests · 11 Jul 2026 · 1 like Requests for platform and documentation features, with the reasoning that justifies them. If you think the site would be better with a feature, suggest it with enough…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #80 · Practice › Interactions · 7 Jul 2026 · 3 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #55 · Access › Insurance & coverage · 5 Jul 2026 · 7 likes Picking up post #52: that is the part I would want checked first. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #19 · Compounds › Retatrutide · 30 Jun 2026 · 1 like Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #102 · Evidence › Journal club · 30 Jun 2026 · 28 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #33 · Practice › Reconstitution · 28 Jun 2026 · 18 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
A revision dispute resolved on the topic rather than in the history Replied, post #9 · Meta › Wiki maintenance · 21 Jun 2026 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Tracking a shortage from primary sources rather than rumour Replied, post #60 · Access › Shortages · 20 Jun 2026 · 16 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #123 · Access › Insurance & coverage · 19 Jun 2026 · 11 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #30 · Practice › Side effects · 18 Jun 2026 · 0 likes post #29 answers the question as asked. The question underneath it is different. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The…
-
Injecting into an area that has become firm: why not to Replied, post #89 · Practice › Administration · 17 Jun 2026 · 8 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #16 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #73 · Access › Pricing · 13 Jun 2026 · 3 likes Picking up post #70: that is the part I would want checked first. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an…
-
Alcohol: what is documented and what is folklore Replied, post #52 · Practice › Interactions · 11 Jun 2026 · 1 like Picking up post #49: that is the part I would want checked first. Food interactions: most interactions are absorption interactions. Some medications absorb better with…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #26 · Research Methods › N-of-1 designs · 9 Jun 2026 · 26 likes Coming back to post #24, because the follow-up matters more than the original answer. When to run an n-of-1: this design works when you want to know whether a treatment…
-
Second pass at: Cagrilintide molecular characteristics and analytical considerations Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 9 Jun 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #73 · Practice › Storage & stability · 6 Jun 2026 · 16 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #109 · Clinical › Bloodwork · 4 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Injection volume, overload, and peak distortion Replied, post #31 · Analytics › HPLC & UHPLC · 2 Jun 2026 · 4 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #24 · Compounds › Semaglutide · 31 May 2026 · 15 likes post #23 answers the question as asked. The question underneath it is different. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Follow-up: Search filters: what is missing Replied, post #115 · Meta › Site feedback · 30 May 2026 · 19 likes post #114 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #59 · Start Here › Welcome · 18 May 2026 · 15 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #5 · Compounds › Secretagogues & GH axis · 17 May 2026 · 0 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
How this community labels and discusses unrefereed work — the long version Replied, post #24 · Evidence › Preprints · 14 May 2026 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Request: show the solution author in the topic list — what changed since Replied, post #25 · Meta › Feature requests · 1 May 2026 · 3 likes I read post #23 twice before replying, because I had assumed the opposite. Alternatives: if you have thought of a way the current site might already serve your need,…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #41 · Evidence › Preprints · 29 Apr 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #85 · Clinical › Bloodwork · 23 Apr 2026 · 1 like Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #48 · Practice › Reconstitution · 20 Apr 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
About the UK & Ireland category Replied, post #7 · Regional › UK & Ireland · 14 Apr 2026 · 26 likes This follows post #4 rather than contradicting it. Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material…
-
Blind submission and why it changes minds — the long version Replied, post #17 · Sourcing › Independent verification · 10 Apr 2026 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Review: an evidence digest and the citation check that delayed it Replied, post #2 · Documentation › Doc review · 9 Apr 2026 · 1 like New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #117 · Research Methods › N-of-1 designs · 29 Mar 2026 · 28 likes Picking up post #114: that is the part I would want checked first. Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #23 · Outcomes › Progress reports · 25 Mar 2026 · 18 likes On post #19 — agreed on the reasoning, with one qualification. Protein intake and resistance training: both self-reported and therefore optimistic in most reports.…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #43 · Evidence › Trials · 25 Mar 2026 · 10 likes post #42 is right about the mechanism and I think understates the practical bit. Open-label design: unblinded trials admit expectation effects. For weight-loss trials…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #12 · Evidence › Journal club · 19 Mar 2026 · 0 likes On post #8 — agreed on the reasoning, with one qualification. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #55 · Sourcing › Logistics · 14 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Grapefruit: why this class is not the class that cares Replied, post #20 · Practice › Interactions · 8 Mar 2026 · 0 likes Worth separating two things that post #16 runs together. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class…
-
The lowest dose that does anything: is that a real question? Replied, post #38 · Practice › Dosing & titration · 3 Mar 2026 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Designing a personal experiment that could change your mind — one year on Replied, post #16 · Research Methods › N-of-1 designs · 1 Mar 2026 · 13 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
A site rotation scheme that is easy enough to actually follow Replied, post #9 · Practice › Administration · 23 Feb 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #20 · Analytics › Impurities & related substances · 22 Feb 2026 · 24 likes Picking up post #17: that is the part I would want checked first. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #75 · Analytics › Impurities & related substances · 20 Feb 2026 · 7 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Bioimpedance and hydration: why the number moves Replied, post #8 · Outcomes › Body composition · 16 Feb 2026 · 23 likes post #7 answers the question as asked. The question underneath it is different. Comparison to published data: the trials reported mean fat and lean mass changes.…
-
Second pass at: Counter-ion content and its effect on measured mass Replied, post #4 · marked as the solution · Analytics › Mass spectrometry · 14 Feb 2026 · 7 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
A calculator that gives a right answer to the wrong question Replied, post #5 · Data & Tools › Calculators · 12 Feb 2026 · 6 likes post #4 answers the question as asked. The question underneath it is different. Precision and significant figures: the calculators do not round to match your input…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #22 · Analytics › Impurities & related substances · 12 Feb 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #13 · Evidence › Study critique · 29 Jan 2026 · 26 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
A parcel stationary at a customs facility for nine days Replied, post #24 · Sourcing › Logistics · 28 Jan 2026 · 21 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How to ask about something you suspect is a bad idea Replied, post #42 · Start Here › How to Ask · 8 Jan 2026 · 15 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
A parcel stationary at a customs facility for nine days Replied, post #11 · Sourcing › Logistics · 11 Dec 2025 · 1 like Worth separating two things that post #7 runs together. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #32 · Sourcing › Independent verification · 4 Dec 2025 · 5 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #44 · Clinical › Special populations · 3 Dec 2025 · 3 likes Picking up post #41: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Tracking a preprint to publication: a worked example Replied, post #25 · Evidence › Preprints · 2 Dec 2025 · 7 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Tracking a preprint to publication: a worked example Replied, post #18 · Evidence › Preprints · 1 Dec 2025 · 7 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Research-use-only labelling: what it means and what it does not Replied, post #66 · Sourcing › Regulatory · 30 Nov 2025 · 9 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #64 · Compounds › Oral incretins · 28 Nov 2025 · 21 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Second pass at: Programming during a large energy deficit Replied, post #82 · Nutrition & Training › Resistance training · 15 Nov 2025 · 26 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
Substitution between formats during a shortage Replied, post #95 · Access › Shortages · 14 Nov 2025 · 27 likes On post #91 — agreed on the reasoning, with one qualification. Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier…
-
Journal club: PIONEER 6 as a safety trial Replied, post #8 · Evidence › Journal club · 11 Nov 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #4 · Practice › Interactions · 8 Nov 2025 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #12 · Compounds › Tirzepatide · 7 Nov 2025 · 9 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
A 40-week log with the measurement method stated Replied, post #77 · Outcomes › Progress reports · 26 Oct 2025 · 0 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #44 · Safety › Adverse events · 22 Oct 2025 · 24 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
New subcategory: rationale and scope Replied, post #50 · Meta › Announcements · 18 Oct 2025 · 0 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Cross-border purchase rules within the EU Replied, post #25 · Regional › European Union · 17 Oct 2025 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Documentation that appears only after payment Replied, post #48 · Sourcing › Red flags · 13 Oct 2025 · 6 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Managing an unplanned gap in supply — what changed since Replied, post #78 · Access › Shortages · 3 Oct 2025 · 30 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #37 · Evidence › Preprints · 28 Sep 2025 · 20 likes Picking up post #34: that is the part I would want checked first. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #71 · Evidence › Journal club · 27 Sep 2025 · 0 likes Picking up post #68: that is the part I would want checked first. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Compounds this community declines to help with, and why Replied, post #5 · Compounds › Other compounds · 23 Sep 2025 · 24 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Thyroid function tests during substantial weight change Replied, post #66 · Clinical › Bloodwork · 18 Sep 2025 · 33 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #66 · Evidence › Journal club · 16 Sep 2025 · 18 likes post #65 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an…
-
[2026 update] Long-time reader, first-time poster Replied, post #10 · Lounge › Introductions · 11 Sep 2025 · 8 likes This follows post #7 rather than contradicting it. Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce…
-
Angle of injection and whether 90 degrees is always right Replied, post #14 · Practice › Administration · 24 Aug 2025 · 5 likes Picking up post #11: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Revisiting: German, French and Dutch differences, compared Replied, post #60 · Regional › European Union · 18 Aug 2025 · 2 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
Comparing two chromatograms from different laboratories, properly Replied, post #4 · Analytics › HPLC & UHPLC · 18 Aug 2025 · 16 likes Coming back to the opening post, because the follow-up matters more than the original answer. Reversed-phase separates on hydrophobicity. A peptide is retained on a…
-
Washout: how long is long enough, and for what purpose Replied, post #55 · Pharmacology › Pharmacokinetics · 13 Aug 2025 · 0 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
What a 2 ppm match establishes, and what it does not Replied, post #41 · Analytics › Mass spectrometry · 12 Aug 2025 · 2 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #13 · Practice › Administration · 8 Aug 2025 · 0 likes This follows post #10 rather than contradicting it. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort),…
-
[2026 update] US compounding rules and how they changed Replied, post #28 · Regional › North America · 30 Jul 2025 · 0 likes Picking up post #25: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
A comparison of home results against a laboratory result on the same vial Replied, post #15 · Analytics › Home & field testing · 17 Jul 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #39 · Clinical › Special populations · 12 Jul 2025 · 8 likes On post #35 — agreed on the reasoning, with one qualification. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin…
-
Pages past their review date, listed Replied, post #5 · Meta › Wiki maintenance · 11 Jul 2025 · 10 likes On the opening post — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
What a documentation review can and cannot tell you Replied, post #29 · Sourcing › Independent verification · 9 Jul 2025 · 0 likes This follows post #26 rather than contradicting it. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #27 · Practice › Dosing & titration · 2 Jul 2025 · 24 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #10 · Data & Tools › Datasets · 21 Jun 2025 · 0 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #26 · Clinical › Special populations · 19 Jun 2025 · 10 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Cost per milligram, computed honestly across formats — a second dataset Replied, post #3 · Access › Pricing · 18 Jun 2025 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #160 · Access › Insurance & coverage · 17 Jun 2025 · 0 likes I read post #158 twice before replying, because I had assumed the opposite. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #134 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 32 likes post #133 is right about the mechanism and I think understates the practical bit. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
Follow-up: Requesting a page: what makes a good request Replied, post #36 · Documentation › Wiki requests · 18 May 2025 · 13 likes Picking up post #33: that is the part I would want checked first. Cross-referencing: if you notice two pages that should reference each other but do not, suggest the…
-
Biological variation versus analytical imprecision Started this topic · Clinical › Bloodwork · 17 May 2025 · 5 likes On the subject in the title: Biological variation versus analytical imprecision Working notes rather than a conclusion. General question, not a request for advice about…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #69 · Sourcing › Independent verification · 9 May 2025 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Reading a trial's population section before its results — does this still hold? Replied, post #56 · Evidence › Trials · 1 May 2025 · 10 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Excipient function in a licensed injectable — the long version Started this topic · Pharmacology › Formulation chemistry · 15 Apr 2025 · 6 likes Posting this under the heading it deserves: Excipient function in a licensed injectable — the long version Everything below is what sits behind that. Working through…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #98 · Documentation › Doc review · 9 Apr 2025 · 0 likes I read post #96 twice before replying, because I had assumed the opposite. Evidence synthesis requests: if you think a page should summarise the state of evidence on a…
-
[2026 update] Documentation that materially improves an appeal's chances Replied, post #2 · Access › Insurance & coverage · 8 Apr 2025 · 1 like I read the opening post twice before replying, because I had assumed the opposite. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #12 · Clinical › Comorbidities · 3 Apr 2025 · 27 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
A promotion I argued against, and why I lost Replied, post #151 · Documentation › Doc review · 28 Mar 2025 · 0 likes Picking up post #148: that is the part I would want checked first. Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does…
-
Units, standards, and other things that quietly hold the world together Replied, post #7 · Lounge › Off topic · 28 Mar 2025 · 0 likes Worth separating two things that post #3 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Asking about a compound your prescriber has not heard of Replied, post #6 · Clinical › Prescriber conversations · 27 Mar 2025 · 27 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #21 · Practice › Interactions · 21 Mar 2025 · 27 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Coming back to: Official shortage notices and what they authorise Replied, post #2 · Access › Shortages · 4 Feb 2025 · 1 like International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Fibre intake when total intake falls, and the constipation link Replied, post #22 · Nutrition & Training › Protein & intake · 29 Jan 2025 · 25 likes This follows post #19 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #13 · Practice › Reconstitution · 28 Jan 2025 · 28 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #70 · Sourcing › Regulatory · 24 Jan 2025 · 4 likes I read post #68 twice before replying, because I had assumed the opposite. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in…
-
A promotion I argued against, and why I lost Replied, post #37 · Documentation › Doc review · 22 Dec 2024 · 14 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #124 · Clinical › Prescriber conversations · 16 Dec 2024 · 3 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Washout with a one-week half-life: the arithmetic Replied, post #20 · Research Methods › N-of-1 designs · 26 Nov 2024 · 30 likes Coming back to post #18, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #134 · Compounds › Other compounds · 22 Nov 2024 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Converting between mg/mL and units per dose, both directions Replied, post #87 · Practice › Reconstitution · 13 Nov 2024 · 0 likes Picking up post #84: that is the part I would want checked first. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #4 · Compounds › Repair & healing peptides · 6 Nov 2024 · 3 likes Worth separating two things that the opening post runs together. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a…
-
Time to steady state after a dose increase Replied, post #8 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 8 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #4 · Clinical › Special populations · 28 Oct 2024 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #5 · Compounds › Other compounds · 18 Oct 2024 · 9 likes I read post #3 twice before replying, because I had assumed the opposite. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #76 · Evidence › Journal club · 17 Oct 2024 · 12 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Taste changes and food aversion, reported and discussed Replied, post #29 · Practice › Side effects · 14 Oct 2024 · 0 likes Picking up post #26: that is the part I would want checked first. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #6 · Sourcing › Regulatory · 2 Oct 2024 · 1 like Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #63 · Compounds › Semaglutide · 21 Sep 2024 · 1 like The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Why a preprint's supplementary material is often the best part Replied, post #10 · Evidence › Preprints · 2 Sep 2024 · 14 likes post #9 is right about the mechanism and I think understates the practical bit. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #53 · Nutrition & Training › Hydration & electrolytes · 22 Aug 2024 · 4 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #25 · Analytics › Mass spectrometry · 15 Aug 2024 · 12 likes Worth separating two things that post #21 runs together. Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress…
-
Promotion criteria, and the one that stops most nominations Replied, post #28 · Documentation › Doc review · 31 Jul 2024 · 0 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #43 · Practice › Interactions · 14 Jul 2024 · 0 likes Picking up post #40: that is the part I would want checked first. Food interactions: most interactions are absorption interactions. Some medications absorb better with…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #133 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes This follows post #130 rather than contradicting it. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Cold packs, phase-change material, and what survives ten days Replied, post #43 · Sourcing › Logistics · 25 Jun 2024 · 0 likes I read post #41 twice before replying, because I had assumed the opposite. Documentation after arrival: photograph the parcel and its contents on arrival. If something…
-
The mass-error checker and its intended scope Replied, post #27 · Data & Tools › Calculators · 3 Jun 2024 · 15 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.